uniQure (QURE) director sells 21,167 shares after exercising options
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
uniQure N.V. director Jack Kaye reported option exercises and share sales. On June 30, 2026, he exercised stock options for a total of 21,167 Ordinary Shares at exercise prices of $20.18 and $37.00, then sold the same number of shares in open-market transactions around $46.43–$46.49 per share. These trades were carried out under a pre-arranged Rule 10b5-1 sales plan adopted on June 16, 2025. After these transactions, he directly owned 25,996 Ordinary Shares.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 21,167 shares ($983,030)
Net Sell
6 txns
Insider
Kaye Jack
Role
null
Sold
21,167 shs ($983K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 4,107 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 17,060 | $0.00 | -- |
| Exercise | Ordinary Shares | 4,107 | $37.00 | $152K |
| Sale | Ordinary Shares | 4,107 | $46.49 | $191K |
| Exercise | Ordinary Shares | 17,060 | $20.18 | $344K |
| Sale | Ordinary Shares | 17,060 | $46.43 | $792K |
Holdings After Transaction:
Stock Option (Right to Buy) — 0 shares (Direct, null);
Ordinary Shares — 30,103 shares (Direct, null)
Footnotes (1)
- The transactions reported herein were effected pursuant to a sales plan adopted by the Reporting Person on June 16, 2025 and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.19 to $46.88. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.19 to $46.80. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in the footnote The Stock Option vested in full on February 25, 2022. The Stock Option vested in full on June 13, 2024.
Key Figures
Shares sold: 21,167 shares
Sale price (17,060 shares): $46.43 per share
Sale price (4,107 shares): $46.49 per share
+3 more
6 metrics
Shares sold
21,167 shares
Ordinary Shares sold in open-market transactions on June 30, 2026
Sale price (17,060 shares)
$46.43 per share
Weighted average price for 17,060 Ordinary Shares sold
Sale price (4,107 shares)
$46.49 per share
Weighted average price for 4,107 Ordinary Shares sold
Options exercised (20.18)
17,060 shares at $20.18
Ordinary Shares acquired via option exercise
Options exercised (37.00)
4,107 shares at $37.00
Ordinary Shares acquired via option exercise
Shares owned after
25,996 shares
Direct Ordinary Share holdings after June 30, 2026 transactions
Key Terms
Rule 10b5-1, weighted average price, Stock Option (Right to Buy), Ordinary Shares, +1 more
5 terms
Rule 10b5-1 regulatory
"intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Stock Option (Right to Buy) financial
"security_title: "Stock Option (Right to Buy)""
open-market sale financial
"transaction_action: "open-market sale""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
What did uniQure (QURE) director Jack Kaye do in this Form 4?
Jack Kaye exercised stock options and sold Ordinary Shares in uniQure. He exercised options for 21,167 shares and sold the same number in open-market transactions, ending with direct ownership of 25,996 shares.
What stock options did Jack Kaye exercise in uniQure (QURE)?
He exercised options covering 21,167 Ordinary Shares in total. This included 17,060 shares at an exercise price of $20.18 and 4,107 shares at an exercise price of $37.00, fully using those option grants.
Was Jack Kaye’s uniQure (QURE) trading done under a Rule 10b5-1 plan?
Yes. The filing states the transactions were executed under a sales plan adopted on June 16, 2025, intended to comply with Rule 10b5-1, meaning the trades were pre-scheduled rather than timed discretionarily.